Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Capitol Capsule: House adopts patent reform, but fee change could be trouble for Senate

This article was originally published in Scrip

Executive Summary

After several years of failed attempts to make US patent reform a reality, the Senate is faced with holding its nose and adopting legislation passed last week by the House that would require funding for the US Patent & Trademark Office (US PTO) to continue to be appropriated by Congress or engage in a battle that could upend any chances of getting a law enacted this year.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC013440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel